APO Research
Talk to an analyst

APO RESEARCH · REPORT

Topical Hemostatic Agents

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Topical Hemostatic Agents Industry Growth and Trends Forecast to 2032

20 December 2025101 pages

Choose your research edition.

Industry ResearchTopical Hemostatic Agents Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Topical Hemostatic Agents Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Topical Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Topical Hemostatic Agents Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Topical Hemostatic Agents Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Topical Hemostatic Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Topical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Topical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Topical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Topical Hemostatic Agents include Pfizer, B Braun Melsungen, Baxter International, Vascular Solutions, The Medicines Company, Marine Polymer Technologies, Integra LifeSciences, Gelita Medical and Ethicon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Topical Hemostatic Agents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Topical Hemostatic Agents market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Topical Hemostatic Agents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Topical Hemostatic Agents.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Topical Hemostatic Agents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Topical Hemostatic Agents Market by Company

Pfizer

B Braun Melsungen

Baxter International

Vascular Solutions

The Medicines Company

Marine Polymer Technologies

Integra LifeSciences

Gelita Medical

Ethicon

Equimedical

C. R. Bard

Anika Therapeutics

Advanced Medical Solutions

Topical Hemostatic Agents Segment by Type

Gelation Sponge

Oxidized Regenerated Cellulose Based Hemostats

Others

Topical Hemostatic Agents Segment by Application

Hospitals

Nursing Homes

Surgical Centers

Topical Hemostatic Agents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Topical Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Hemostatic Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Topical Hemostatic Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Topical Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Gelation Sponge Table 2. Major Company of Oxidized Regenerated Cellulose Based Hemostats Table 3. Major Company of Others Table 4. Global Topical Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Topical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 6. Global Topical Hemostatic Agents Sales Market Share in Volume by Type (2021-2026) Table 7. Global Topical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 8. Global Topical Hemostatic Agents Sales Market Share in Value by Type (2021-2026) Table 9. Global Topical Hemostatic Agents Price by Type (2021-2026) & (US$/Unit) Table 10. Global Topical Hemostatic Agents Sales by Type (2027-2032) & (K Units) Table 11. Global Topical Hemostatic Agents Sales Market Share in Volume by Type (2027-2032) Table 12. Global Topical Hemostatic Agents Sales by Type (2027-2032) & (US$ Million) Table 13. Global Topical Hemostatic Agents Sales Market Share in Value by Type (2027-2032) Table 14. Global Topical Hemostatic Agents Price by Type (2027-2032) & (US$/Unit) Table 15. North America Topical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 16. North America Topical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Topical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 18. Europe Topical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Topical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Topical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Topical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 22. Latin America Topical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Topical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Topical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 25. Topical Hemostatic Agents Industry Trends Table 26. Topical Hemostatic Agents Industry Drivers Table 27. Topical Hemostatic Agents Industry Opportunities and Challenges Table 28. Topical Hemostatic Agents Industry Restraints Table 29. Global Topical Hemostatic Agents Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Topical Hemostatic Agents Revenue Market Share by Company (2021-2026) Table 31. Global Topical Hemostatic Agents Sales by Company (2021-2026) & (K Units) Table 32. Global Topical Hemostatic Agents Sales Share by Company (2021-2026) Table 33. Global Topical Hemostatic Agents Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Topical Hemostatic Agents Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Topical Hemostatic Agents Major Company Production Sites and Headquarters Table 36. Global Topical Hemostatic Agents Company, Product Type & Application Table 37. Global Topical Hemostatic Agents Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Topical Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Topical Hemostatic Agents Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Topical Hemostatic Agents Sales by Region (2021-2026) & (K Units) Table 42. Global Topical Hemostatic Agents Sales Market Share in Volume by Region (2021-2026) Table 43. Global Topical Hemostatic Agents Sales by Region (2021-2026) & (US$ Million) Table 44. Global Topical Hemostatic Agents Sales Market Share in Value by Region (2021-2026) Table 45. Global Topical Hemostatic Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Topical Hemostatic Agents Sales by Region (2027-2032) & (K Units) Table 47. Global Topical Hemostatic Agents Sales Market Share in Volume by Region (2027-2032) Table 48. Global Topical Hemostatic Agents Sales by Region (2027-2032) & (US$ Million) Table 49. Global Topical Hemostatic Agents Sales Market Share in Value by Region (2027-2032) Table 50. Global Topical Hemostatic Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Topical Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Topical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 53. Global Topical Hemostatic Agents Sales Market Share in Volume by Application (2021-2026) Table 54. Global Topical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 55. Global Topical Hemostatic Agents Sales Market Share in Value by Application (2021-2026) Table 56. Global Topical Hemostatic Agents Price by Application (2021-2026) & (US$/Unit) Table 57. Global Topical Hemostatic Agents Sales by Application (2027-2032) & (K Units) Table 58. Global Topical Hemostatic Agents Sales Market Share in Volume by Application (2027-2032) Table 59. Global Topical Hemostatic Agents Sales by Application (2027-2032) & (US$ Million) Table 60. Global Topical Hemostatic Agents Sales Market Share in Value by Application (2027-2032) Table 61. Global Topical Hemostatic Agents Price by Application (2027-2032) & (US$/Unit) Table 62. North America Topical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 63. North America Topical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Topical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 65. Europe Topical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Topical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Topical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Topical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 69. Latin America Topical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Topical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Topical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Pfizer Topical Hemostatic Agents Product Portfolio Table 76. Pfizer Recent Development Table 77. B Braun Melsungen Company Information Table 78. B Braun Melsungen Business Overview Table 79. B Braun Melsungen Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. B Braun Melsungen Topical Hemostatic Agents Product Portfolio Table 81. B Braun Melsungen Recent Development Table 82. Baxter International Company Information Table 83. Baxter International Business Overview Table 84. Baxter International Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Baxter International Topical Hemostatic Agents Product Portfolio Table 86. Baxter International Recent Development Table 87. Vascular Solutions Company Information Table 88. Vascular Solutions Business Overview Table 89. Vascular Solutions Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Vascular Solutions Topical Hemostatic Agents Product Portfolio Table 91. Vascular Solutions Recent Development Table 92. The Medicines Company Company Information Table 93. The Medicines Company Business Overview Table 94. The Medicines Company Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. The Medicines Company Topical Hemostatic Agents Product Portfolio Table 96. The Medicines Company Recent Development Table 97. Marine Polymer Technologies Company Information Table 98. Marine Polymer Technologies Business Overview Table 99. Marine Polymer Technologies Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Marine Polymer Technologies Topical Hemostatic Agents Product Portfolio Table 101. Marine Polymer Technologies Recent Development Table 102. Integra LifeSciences Company Information Table 103. Integra LifeSciences Business Overview Table 104. Integra LifeSciences Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Integra LifeSciences Topical Hemostatic Agents Product Portfolio Table 106. Integra LifeSciences Recent Development Table 107. Gelita Medical Company Information Table 108. Gelita Medical Business Overview Table 109. Gelita Medical Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Gelita Medical Topical Hemostatic Agents Product Portfolio Table 111. Gelita Medical Recent Development Table 112. Ethicon Company Information Table 113. Ethicon Business Overview Table 114. Ethicon Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Ethicon Topical Hemostatic Agents Product Portfolio Table 116. Ethicon Recent Development Table 117. Equimedical Company Information Table 118. Equimedical Business Overview Table 119. Equimedical Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Equimedical Topical Hemostatic Agents Product Portfolio Table 121. Equimedical Recent Development Table 122. C. R. Bard Company Information Table 123. C. R. Bard Business Overview Table 124. C. R. Bard Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. C. R. Bard Topical Hemostatic Agents Product Portfolio Table 126. C. R. Bard Recent Development Table 127. Anika Therapeutics Company Information Table 128. Anika Therapeutics Business Overview Table 129. Anika Therapeutics Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Anika Therapeutics Topical Hemostatic Agents Product Portfolio Table 131. Anika Therapeutics Recent Development Table 132. Advanced Medical Solutions Company Information Table 133. Advanced Medical Solutions Business Overview Table 134. Advanced Medical Solutions Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Advanced Medical Solutions Topical Hemostatic Agents Product Portfolio Table 136. Advanced Medical Solutions Recent Development Table 137. North America Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. North America Topical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 139. North America Topical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 140. North America Topical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 141. North America Topical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 142. North America Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Topical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Topical Hemostatic Agents Market Share by Country (2021-2026) Table 145. North America Topical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Topical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 147. Europe Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Europe Topical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 149. Europe Topical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 150. Europe Topical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 151. Europe Topical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Topical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Topical Hemostatic Agents Market Share by Country (2021-2026) Table 155. Europe Topical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Topical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Topical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 159. Asia-Pacific Topical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Topical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 161. Asia-Pacific Topical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Topical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Topical Hemostatic Agents Market Share by Country (2021-2026) Table 165. Asia-Pacific Topical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Topical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 167. Latin America Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Latin America Topical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 169. Latin America Topical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 170. Latin America Topical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 171. Latin America Topical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Topical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Topical Hemostatic Agents Market Share by Country (2021-2026) Table 175. Latin America Topical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Topical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Topical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 179. Middle East and Africa Topical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Topical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 181. Middle East and Africa Topical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Topical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Topical Hemostatic Agents Market Share by Country (2021-2026) Table 185. Middle East and Africa Topical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Topical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Topical Hemostatic Agents Distributors List Table 190. Topical Hemostatic Agents Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Topical Hemostatic Agents Image Figure 2. Global Topical Hemostatic Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Topical Hemostatic Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Topical Hemostatic Agents Sales (2021-2032) & (K Units) Figure 5. Gelation Sponge Image Figure 6. Global Gelation Sponge Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oxidized Regenerated Cellulose Based Hemostats Image Figure 8. Global Oxidized Regenerated Cellulose Based Hemostats Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Topical Hemostatic Agents Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Topical Hemostatic Agents Market Share by Type 2025 VS 2032 Figure 13. North America Topical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 14. North America Topical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 15. Europe Topical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 16. Europe Topical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Topical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Topical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 19. Latin America Topical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Topical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Topical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Topical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Topical Hemostatic Agents Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Nursing Homes Image Figure 28. Global Nursing Homes Sales YoY Growth (2021-2032) & (K Units) Figure 29. Surgical Centers Image Figure 30. Global Surgical Centers Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Topical Hemostatic Agents Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Topical Hemostatic Agents Market Share by Application 2025 VS 2032 Figure 33. North America Topical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 34. North America Topical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 35. Europe Topical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 36. Europe Topical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Topical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Topical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 39. Latin America Topical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Topical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Topical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Topical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 43. North America Topical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Topical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Topical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Topical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Topical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Topical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Topical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Topical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Topical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Topical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Topical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Topical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Topical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Topical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Topical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Topical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Topical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Topical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Topical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Topical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Topical Hemostatic Agents Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Topical Hemostatic Agents Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Gelation Sponge
  • Oxidized Regenerated Cellulose Based Hemostats
  • Others
Applications
  • Hospitals
  • Nursing Homes
  • Surgical Centers
Companies covered
  • Pfizer
  • B Braun Melsungen
  • Baxter International
  • Vascular Solutions
  • The Medicines Company
  • Marine Polymer Technologies
  • Integra LifeSciences
  • Gelita Medical
  • Ethicon
  • Equimedical
  • C. R. Bard
  • Anika Therapeutics
  • Advanced Medical Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Topical Hemostatic Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Topical Hemostatic Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Topical Hemostatic Agents Market by Type
  6. 1.3.1 Gelation Sponge
  7. 1.3.2 Oxidized Regenerated Cellulose Based Hemostats
  8. 1.3.3 Others
  9. 1.4 Global Topical Hemostatic Agents Market Size by Type
  10. 1.4.1 Global Topical Hemostatic Agents Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Topical Hemostatic Agents Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Topical Hemostatic Agents Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Topical Hemostatic Agents Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Topical Hemostatic Agents Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Topical Hemostatic Agents Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Topical Hemostatic Agents Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Topical Hemostatic Agents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Topical Hemostatic Agents Industry Trends
  2. 2.2 Topical Hemostatic Agents Industry Drivers
  3. 2.3 Topical Hemostatic Agents Industry Opportunities and Challenges
  4. 2.4 Topical Hemostatic Agents Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Topical Hemostatic Agents Revenue (2021-2026)
  2. 3.2 Global Top Players by Topical Hemostatic Agents Sales (2021-2026)
  3. 3.3 Global Top Players by Topical Hemostatic Agents Price (2021-2026)
  4. 3.4 Global Topical Hemostatic Agents Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Topical Hemostatic Agents Major Company Production Sites & Headquarters
  6. 3.6 Global Topical Hemostatic Agents Company, Product Type & Application
  7. 3.7 Global Topical Hemostatic Agents Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Topical Hemostatic Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Topical Hemostatic Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Topical Hemostatic Agents Tier 1, Tier 2, and Tier 3
4 Topical Hemostatic Agents Regional Status and Outlook
  1. 4.1 Global Topical Hemostatic Agents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Topical Hemostatic Agents Historic Market Size by Region
  3. 4.2.1 Global Topical Hemostatic Agents Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Topical Hemostatic Agents Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Topical Hemostatic Agents Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Topical Hemostatic Agents Forecasted Market Size by Region
  7. 4.3.1 Global Topical Hemostatic Agents Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Topical Hemostatic Agents Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Topical Hemostatic Agents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Topical Hemostatic Agents by Application
  1. 5.1 Topical Hemostatic Agents Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Nursing Homes
  4. 5.1.3 Surgical Centers
  5. 5.2 Global Topical Hemostatic Agents Market Size by Application
  6. 5.2.1 Global Topical Hemostatic Agents Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Topical Hemostatic Agents Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Topical Hemostatic Agents Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Topical Hemostatic Agents Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Topical Hemostatic Agents Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Topical Hemostatic Agents Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Topical Hemostatic Agents Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Topical Hemostatic Agents Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Topical Hemostatic Agents Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 B Braun Melsungen
  8. 6.2.1 B Braun Melsungen Company Information
  9. 6.2.2 B Braun Melsungen Business Overview
  10. 6.2.3 B Braun Melsungen Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 B Braun Melsungen Topical Hemostatic Agents Product Portfolio
  12. 6.2.5 B Braun Melsungen Recent Developments
  13. 6.3 Baxter International
  14. 6.3.1 Baxter International Company Information
  15. 6.3.2 Baxter International Business Overview
  16. 6.3.3 Baxter International Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Baxter International Topical Hemostatic Agents Product Portfolio
  18. 6.3.5 Baxter International Recent Developments
  19. 6.4 Vascular Solutions
  20. 6.4.1 Vascular Solutions Company Information
  21. 6.4.2 Vascular Solutions Business Overview
  22. 6.4.3 Vascular Solutions Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Vascular Solutions Topical Hemostatic Agents Product Portfolio
  24. 6.4.5 Vascular Solutions Recent Developments
  25. 6.5 The Medicines Company
  26. 6.5.1 The Medicines Company Company Information
  27. 6.5.2 The Medicines Company Business Overview
  28. 6.5.3 The Medicines Company Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 The Medicines Company Topical Hemostatic Agents Product Portfolio
  30. 6.5.5 The Medicines Company Recent Developments
  31. 6.6 Marine Polymer Technologies
  32. 6.6.1 Marine Polymer Technologies Company Information
  33. 6.6.2 Marine Polymer Technologies Business Overview
  34. 6.6.3 Marine Polymer Technologies Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Marine Polymer Technologies Topical Hemostatic Agents Product Portfolio
  36. 6.6.5 Marine Polymer Technologies Recent Developments
  37. 6.7 Integra LifeSciences
  38. 6.7.1 Integra LifeSciences Company Information
  39. 6.7.2 Integra LifeSciences Business Overview
  40. 6.7.3 Integra LifeSciences Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Integra LifeSciences Topical Hemostatic Agents Product Portfolio
  42. 6.7.5 Integra LifeSciences Recent Developments
  43. 6.8 Gelita Medical
  44. 6.8.1 Gelita Medical Company Information
  45. 6.8.2 Gelita Medical Business Overview
  46. 6.8.3 Gelita Medical Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Gelita Medical Topical Hemostatic Agents Product Portfolio
  48. 6.8.5 Gelita Medical Recent Developments
  49. 6.9 Ethicon
  50. 6.9.1 Ethicon Company Information
  51. 6.9.2 Ethicon Business Overview
  52. 6.9.3 Ethicon Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ethicon Topical Hemostatic Agents Product Portfolio
  54. 6.9.5 Ethicon Recent Developments
  55. 6.10 Equimedical
  56. 6.10.1 Equimedical Company Information
  57. 6.10.2 Equimedical Business Overview
  58. 6.10.3 Equimedical Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Equimedical Topical Hemostatic Agents Product Portfolio
  60. 6.10.5 Equimedical Recent Developments
  61. 6.11 C. R. Bard
  62. 6.11.1 C. R. Bard Company Information
  63. 6.11.2 C. R. Bard Business Overview
  64. 6.11.3 C. R. Bard Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 C. R. Bard Topical Hemostatic Agents Product Portfolio
  66. 6.11.5 C. R. Bard Recent Developments
  67. 6.12 Anika Therapeutics
  68. 6.12.1 Anika Therapeutics Company Information
  69. 6.12.2 Anika Therapeutics Business Overview
  70. 6.12.3 Anika Therapeutics Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Anika Therapeutics Topical Hemostatic Agents Product Portfolio
  72. 6.12.5 Anika Therapeutics Recent Developments
  73. 6.13 Advanced Medical Solutions
  74. 6.13.1 Advanced Medical Solutions Company Information
  75. 6.13.2 Advanced Medical Solutions Business Overview
  76. 6.13.3 Advanced Medical Solutions Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Advanced Medical Solutions Topical Hemostatic Agents Product Portfolio
  78. 6.13.5 Advanced Medical Solutions Recent Developments
7 North America by Country
  1. 7.1 North America Topical Hemostatic Agents Sales by Country
  2. 7.1.1 North America Topical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Topical Hemostatic Agents Sales by Country (2021-2026)
  4. 7.1.3 North America Topical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 7.2 North America Topical Hemostatic Agents Market Size by Country
  6. 7.2.1 North America Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Topical Hemostatic Agents Market Size by Country (2021-2026)
  8. 7.2.3 North America Topical Hemostatic Agents Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Topical Hemostatic Agents Sales by Country
  2. 8.1.1 Europe Topical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Topical Hemostatic Agents Sales by Country (2021-2026)
  4. 8.1.3 Europe Topical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Topical Hemostatic Agents Market Size by Country
  6. 8.2.1 Europe Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Topical Hemostatic Agents Market Size by Country (2021-2026)
  8. 8.2.3 Europe Topical Hemostatic Agents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Topical Hemostatic Agents Sales by Country
  2. 9.1.1 Asia-Pacific Topical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Topical Hemostatic Agents Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Topical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Topical Hemostatic Agents Market Size by Country
  6. 9.2.1 Asia-Pacific Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Topical Hemostatic Agents Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Topical Hemostatic Agents Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Topical Hemostatic Agents Sales by Country
  2. 10.1.1 South America Topical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Topical Hemostatic Agents Sales by Country (2021-2026)
  4. 10.1.3 South America Topical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 10.2 South America Topical Hemostatic Agents Market Size by Country
  6. 10.2.1 South America Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Topical Hemostatic Agents Market Size by Country (2021-2026)
  8. 10.2.3 South America Topical Hemostatic Agents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Topical Hemostatic Agents Sales by Country
  2. 11.1.1 Middle East and Africa Topical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Topical Hemostatic Agents Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Topical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Topical Hemostatic Agents Market Size by Country
  6. 11.2.1 Middle East and Africa Topical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Topical Hemostatic Agents Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Topical Hemostatic Agents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Topical Hemostatic Agents Value Chain Analysis
  2. 12.1.1 Topical Hemostatic Agents Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Topical Hemostatic Agents Production Mode & Process
  7. 12.2 Topical Hemostatic Agents Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Topical Hemostatic Agents Distributors
  10. 12.2.3 Topical Hemostatic Agents Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst